{"References": [{"title": "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing", "authors": "Marco Gerlinger, Andrew J. Rowan, Stuart Horswell, James Larkin, David J. Endesfelder, Emma Gronroos, Katharina Martinez, Nicholas Matthews, Graham Stewart, David Tarpey, Elinor Varela, Lucy Phillimore, Sarah Begum, David McDonald, Helen Butler, David Jones, David Raine, David Latimer, David A. Santos, David N. Nohadani, David Eklund, David Spencer-Dene, David Clark, David Pickering, David Stamp, David Gore, David Szallasi, David Downward, David Futreal, David Swanton", "journal": "New England Journal of Medicine", "year": "2012", "volumes": "366", "first page": "883", "last page": "892", "DOI": "10.1056/NEJMoa1113205"}, {"title": "Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion", "authors": "Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth", "journal": "Science", "year": "2011", "volumes": "331", "first page": "1565", "last page": "1570", "DOI": "10.1126/science.1203486"}, {"title": "The immune contexture in human tumours: impact on clinical outcome", "authors": "Jerome Galon, Wolf H. Fridman, Franck Pag√®s", "journal": "Nature Reviews Cancer", "year": "2007", "volumes": "7", "first page": "215", "last page": "229", "DOI": "10.1038/nrc2063"}, {"title": "Immune checkpoint blockade in cancer therapy: Toward combination strategies with curative potential", "authors": "James P. Allison, Padmanee Sharma", "journal": "Cell", "year": "2015", "volumes": "161", "first page": "205", "last page": "214", "DOI": "10.1016/j.cell.2015.03.030"}, {"title": "The role of clonal evolution in cancer", "authors": "Charles Swanton", "journal": "Nature", "year": "2012", "volumes": "482", "first page": "306", "last page": "313", "DOI": "10.1038/nature10762"}, {"title": "Tumor heterogeneity and resistance to cancer therapies", "authors": "Charles Swanton", "journal": "Nature Reviews Clinical Oncology", "year": "2012", "volumes": "9", "first page": "132", "last page": "142", "DOI": "10.1038/nrclinonc.2011.166"}, {"title": "The cancer immunoediting hypothesis: how does it impact the design of new cancer immunotherapies?", "authors": "Mark J. Smyth, Gabrielle P. Dunn, Robert D. Schreiber", "journal": "Nature Reviews Cancer", "year": "2006", "volumes": "6", "first page": "513", "last page": "523", "DOI": "10.1038/nrc1946"}, {"title": "Mechanisms of immune evasion in cancer", "authors": "George Coukos, Olivera J. Finn, Lisa H. Butterfield", "journal": "Immunological Reviews", "year": "2011", "volumes": "241", "first page": "29", "last page": "48", "DOI": "10.1111/j.1600-065X.2011.01005.x"}, {"title": "The evolving landscape of biomarkers for checkpoint inhibitor therapy", "authors": "Antoni Ribas, Padmanee Sharma", "journal": "Nature Reviews Cancer", "year": "2018", "volumes": "18", "first page": "133", "last page": "150", "DOI": "10.1038/nrc.2017.150"}, {"title": "Clonal heterogeneity in cancer and its implications for therapy", "authors": "Nicholas McGranahan, Charles Swanton", "journal": "Nature", "year": "2017", "volumes": "548", "first page": "339", "last page": "346", "DOI": "10.1038/nature22368"}]}